Local society calls for insurance revision over hyperlipidemic treatment

Published: 2008-01-29 06:58:00

Updated: 2008-01-29 06:58:00

The current health insurance allowance for the treatment of hyperlipidemia needs to be revised depending on the levels of low-density lipoprotein (LDL) cholesterol, instead of total cholesterol levels, according to the Korean Society of Lipidology and Atherosclerosis.

Currently, the national health insurance fund does not cover any risk factor for cardiovascular disease in patients with hype...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.